HAEMONETICS is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

Roche provides blood screening and diagnostic tests used worldwide to improve blood and blood product safety, diagnose disease, monitor progression and response to therapy, and identify gene‑based factors to aid in treatment selection. Roche's fully automated, real‑time PCR cobas s 201 system and the multiplex blood screening test for HIV‑1, HIV‑2, HCV and HBV ‑ the most comprehensive multiplex NAT test available ‑ enable improved blood safety and workflow efficiency. http://molecular.roche.com/blood_screening

The Binding Site Ltd is a British manufacturing company specialising in the development and production of high quality immunology diagnostic assays and reagents. In recent years the Binding Site has worked closely with our customers to develop assays with applications specific to industry. These include assays to measure high levels of Tetanus IgG and Varicella-zoster IgG during the screening of plasma donor units. Previously clinical range assays had to be adapted by the customer for this purpose. As specialists in the detection of serum and plasma proteins, the Binding Site also has a wide variety of research reagents and control fluids available. Our experience in producing and supplying specific antisera for both manufacture of our own diagnostic assays, and those of other manufacturers, enables us optimise these reagents if necessary.

For more information visit www.bindingsite.co.uk or come and see us at our exhibition stand.

A pioneer in transfusion medicine, Fenwal Inc. is one of the world’s largest suppliers of advanced technologies that help ensure a safe and plentiful global blood supply. With a singular focus on transfusion medicine, the newly independent Fenwal reignites its passion and commitment to helping is customers save and improve lives. Building on our nearly 60-year heritage of developing innovative solutions to meet the needs of blood and plasma centers, donors and recipients, our global team is focused on the research and development, manufacturing and marketing of innovative products for the collection, processing and storage of blood and blood components. For more information visit www.fenwalinc.com .

Design and Construction of Blood Plasma Fractionation Plants, Pharmaceutical and Biotechnology Plants by Linde-KCA-Dresden GmbH

Linde-KCA-Dresden GmbH is a full service engineering contractor, well experienced in the field of general pharmaceutical plants and particularly in blood plasma fractionation plants, biotechnology and API plants. We design, manage and execute projects from the preliminary concept to the completed plant or provide any combination of individual services for customized solutions.

Contact:
Dr. Reinhold Bronnenmeier
Business Development Biotechnology Plants
Linde-KCA-Dresden GmbH
p.o.Box 210353,
01265 Dresden, Germany
phone: + 49 (0) 351 250 3542
facsimile: +49 (0) 351 250 4814
email: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it